PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest specialty financing provider to innovative venture, growth and established stage ...
In May 2019, Hercules' portfolio company Dermavant Sciences, Inc., a wholly owned subsidiary of Roivant Sciences, and a clinical-stage biopharmaceutical company dedicated to developing and ...